Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study
Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2016-07, Vol.34 (34), p.4046-4049 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4049 |
|---|---|
| container_issue | 34 |
| container_start_page | 4046 |
| container_title | Vaccine |
| container_volume | 34 |
| creator | Langley, J.M MacDougall, D.M Halperin, B.A Swain, A Halperin, S.A Top, K.A McNeil, S.A MacKinnon-Cameron, D Marty, K De Serres, G Dubé, E Bettinger, J.A |
| description | Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical trials. |
| doi_str_mv | 10.1016/j.vaccine.2016.06.025 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808655112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X16304388</els_id><sourcerecordid>4120765081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-c613dfc962c50b30a4b30590e4d1688cc507ee98c837f4be17831501f13daebf3</originalsourceid><addsrcrecordid>eNqNkt-L1DAQx4so3nr6JygBX3zpmjRNm_rgcS7-ODgUTgXfQjad3mavTdYk7bH-L_6vTtlV4V4UQsIMn5nMzHey7CmjS0ZZ9XK7nLQx1sGyQHNJ8RTiXrZgsuZ5IZi8ny1oUZV5yei3k-xRjFtKqeCseZidFDWnBedykf280jvbkjiGCWzfa2eAdD6QDeg-bQhM4FJET9_7W-uuiSaDjpEM4NDyxhuje_KGHGshu-Cvgx6IdUiOzk4Qok17EiElDHhFzslKO91a7cjFMCDxQyfrHbmCCDqYDfkI6daHGxLT2O4fZw863Ud4cnxPs6_v3n5ZfcgvP72_WJ1f5qaULOWmYrztTFMVRtA1p7rESzQUypZVUhr01gCNNJLXXbkGVkvOBGUdhmlYd_w0e3HIi_V_HyEmNdhoYJ4H-DEqJqmshGCs-B-Ul4JXskH0-R1068fgsJGZEiVWTSVS4kCZ4GMM0KldsIMOe8WomqVWW3Ucr5qlVhRPITDu2TH7uB6g_RP1W1sEzg4A4OQmC0FFYwEFbm0Ak1Tr7T-_eH0ng-mtsyj5Dewh_u1GxUJR9Xnet3ndWMVpyaXkvwBEG9OM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805461308</pqid></control><display><type>article</type><title>Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Langley, J.M ; MacDougall, D.M ; Halperin, B.A ; Swain, A ; Halperin, S.A ; Top, K.A ; McNeil, S.A ; MacKinnon-Cameron, D ; Marty, K ; De Serres, G ; Dubé, E ; Bettinger, J.A</creator><creatorcontrib>Langley, J.M ; MacDougall, D.M ; Halperin, B.A ; Swain, A ; Halperin, S.A ; Top, K.A ; McNeil, S.A ; MacKinnon-Cameron, D ; Marty, K ; De Serres, G ; Dubé, E ; Bettinger, J.A</creatorcontrib><description>Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical trials.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2016.06.025</identifier><identifier>PMID: 27302338</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age ; Allergy and Immunology ; Canada ; Clinical trials ; College campuses ; Demographics ; Disease ; Disease outbreaks ; Emergency medical services ; Fatalities ; Female ; Health problems ; Health surveillance ; Humans ; Immunization ; Influenza ; Internet ; Male ; Mass Vaccination ; Medical research ; Meningococcal Infections - prevention & control ; Meningococcal Vaccines - administration & dosage ; Meningococcal Vaccines - adverse effects ; Meningococcal Vaccines - therapeutic use ; Neisseria meningitidis ; Neisseria meningitidis group B ; Neisseria meningitidis, Serogroup B ; Population Surveillance ; Product Surveillance, Postmarketing ; Public health ; Regulatory approval ; Response rates ; Student health services ; Students ; Surveys and Questionnaires ; Universities ; Vaccination - adverse effects ; Vaccines ; Young Adult</subject><ispartof>Vaccine, 2016-07, Vol.34 (34), p.4046-4049</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul 25, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-c613dfc962c50b30a4b30590e4d1688cc507ee98c837f4be17831501f13daebf3</citedby><cites>FETCH-LOGICAL-c481t-c613dfc962c50b30a4b30590e4d1688cc507ee98c837f4be17831501f13daebf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X16304388$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27302338$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Langley, J.M</creatorcontrib><creatorcontrib>MacDougall, D.M</creatorcontrib><creatorcontrib>Halperin, B.A</creatorcontrib><creatorcontrib>Swain, A</creatorcontrib><creatorcontrib>Halperin, S.A</creatorcontrib><creatorcontrib>Top, K.A</creatorcontrib><creatorcontrib>McNeil, S.A</creatorcontrib><creatorcontrib>MacKinnon-Cameron, D</creatorcontrib><creatorcontrib>Marty, K</creatorcontrib><creatorcontrib>De Serres, G</creatorcontrib><creatorcontrib>Dubé, E</creatorcontrib><creatorcontrib>Bettinger, J.A</creatorcontrib><title>Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical trials.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Allergy and Immunology</subject><subject>Canada</subject><subject>Clinical trials</subject><subject>College campuses</subject><subject>Demographics</subject><subject>Disease</subject><subject>Disease outbreaks</subject><subject>Emergency medical services</subject><subject>Fatalities</subject><subject>Female</subject><subject>Health problems</subject><subject>Health surveillance</subject><subject>Humans</subject><subject>Immunization</subject><subject>Influenza</subject><subject>Internet</subject><subject>Male</subject><subject>Mass Vaccination</subject><subject>Medical research</subject><subject>Meningococcal Infections - prevention & control</subject><subject>Meningococcal Vaccines - administration & dosage</subject><subject>Meningococcal Vaccines - adverse effects</subject><subject>Meningococcal Vaccines - therapeutic use</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis group B</subject><subject>Neisseria meningitidis, Serogroup B</subject><subject>Population Surveillance</subject><subject>Product Surveillance, Postmarketing</subject><subject>Public health</subject><subject>Regulatory approval</subject><subject>Response rates</subject><subject>Student health services</subject><subject>Students</subject><subject>Surveys and Questionnaires</subject><subject>Universities</subject><subject>Vaccination - adverse effects</subject><subject>Vaccines</subject><subject>Young Adult</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkt-L1DAQx4so3nr6JygBX3zpmjRNm_rgcS7-ODgUTgXfQjad3mavTdYk7bH-L_6vTtlV4V4UQsIMn5nMzHey7CmjS0ZZ9XK7nLQx1sGyQHNJ8RTiXrZgsuZ5IZi8ny1oUZV5yei3k-xRjFtKqeCseZidFDWnBedykf280jvbkjiGCWzfa2eAdD6QDeg-bQhM4FJET9_7W-uuiSaDjpEM4NDyxhuje_KGHGshu-Cvgx6IdUiOzk4Qok17EiElDHhFzslKO91a7cjFMCDxQyfrHbmCCDqYDfkI6daHGxLT2O4fZw863Ud4cnxPs6_v3n5ZfcgvP72_WJ1f5qaULOWmYrztTFMVRtA1p7rESzQUypZVUhr01gCNNJLXXbkGVkvOBGUdhmlYd_w0e3HIi_V_HyEmNdhoYJ4H-DEqJqmshGCs-B-Ul4JXskH0-R1068fgsJGZEiVWTSVS4kCZ4GMM0KldsIMOe8WomqVWW3Ucr5qlVhRPITDu2TH7uB6g_RP1W1sEzg4A4OQmC0FFYwEFbm0Ak1Tr7T-_eH0ng-mtsyj5Dewh_u1GxUJR9Xnet3ndWMVpyaXkvwBEG9OM</recordid><startdate>20160725</startdate><enddate>20160725</enddate><creator>Langley, J.M</creator><creator>MacDougall, D.M</creator><creator>Halperin, B.A</creator><creator>Swain, A</creator><creator>Halperin, S.A</creator><creator>Top, K.A</creator><creator>McNeil, S.A</creator><creator>MacKinnon-Cameron, D</creator><creator>Marty, K</creator><creator>De Serres, G</creator><creator>Dubé, E</creator><creator>Bettinger, J.A</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7U2</scope></search><sort><creationdate>20160725</creationdate><title>Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study</title><author>Langley, J.M ; MacDougall, D.M ; Halperin, B.A ; Swain, A ; Halperin, S.A ; Top, K.A ; McNeil, S.A ; MacKinnon-Cameron, D ; Marty, K ; De Serres, G ; Dubé, E ; Bettinger, J.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-c613dfc962c50b30a4b30590e4d1688cc507ee98c837f4be17831501f13daebf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Allergy and Immunology</topic><topic>Canada</topic><topic>Clinical trials</topic><topic>College campuses</topic><topic>Demographics</topic><topic>Disease</topic><topic>Disease outbreaks</topic><topic>Emergency medical services</topic><topic>Fatalities</topic><topic>Female</topic><topic>Health problems</topic><topic>Health surveillance</topic><topic>Humans</topic><topic>Immunization</topic><topic>Influenza</topic><topic>Internet</topic><topic>Male</topic><topic>Mass Vaccination</topic><topic>Medical research</topic><topic>Meningococcal Infections - prevention & control</topic><topic>Meningococcal Vaccines - administration & dosage</topic><topic>Meningococcal Vaccines - adverse effects</topic><topic>Meningococcal Vaccines - therapeutic use</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis group B</topic><topic>Neisseria meningitidis, Serogroup B</topic><topic>Population Surveillance</topic><topic>Product Surveillance, Postmarketing</topic><topic>Public health</topic><topic>Regulatory approval</topic><topic>Response rates</topic><topic>Student health services</topic><topic>Students</topic><topic>Surveys and Questionnaires</topic><topic>Universities</topic><topic>Vaccination - adverse effects</topic><topic>Vaccines</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Langley, J.M</creatorcontrib><creatorcontrib>MacDougall, D.M</creatorcontrib><creatorcontrib>Halperin, B.A</creatorcontrib><creatorcontrib>Swain, A</creatorcontrib><creatorcontrib>Halperin, S.A</creatorcontrib><creatorcontrib>Top, K.A</creatorcontrib><creatorcontrib>McNeil, S.A</creatorcontrib><creatorcontrib>MacKinnon-Cameron, D</creatorcontrib><creatorcontrib>Marty, K</creatorcontrib><creatorcontrib>De Serres, G</creatorcontrib><creatorcontrib>Dubé, E</creatorcontrib><creatorcontrib>Bettinger, J.A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Safety Science and Risk</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Langley, J.M</au><au>MacDougall, D.M</au><au>Halperin, B.A</au><au>Swain, A</au><au>Halperin, S.A</au><au>Top, K.A</au><au>McNeil, S.A</au><au>MacKinnon-Cameron, D</au><au>Marty, K</au><au>De Serres, G</au><au>Dubé, E</au><au>Bettinger, J.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2016-07-25</date><risdate>2016</risdate><volume>34</volume><issue>34</issue><spage>4046</spage><epage>4049</epage><pages>4046-4049</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical trials.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27302338</pmid><doi>10.1016/j.vaccine.2016.06.025</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2016-07, Vol.34 (34), p.4046-4049 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1808655112 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adolescent Adult Age Allergy and Immunology Canada Clinical trials College campuses Demographics Disease Disease outbreaks Emergency medical services Fatalities Female Health problems Health surveillance Humans Immunization Influenza Internet Male Mass Vaccination Medical research Meningococcal Infections - prevention & control Meningococcal Vaccines - administration & dosage Meningococcal Vaccines - adverse effects Meningococcal Vaccines - therapeutic use Neisseria meningitidis Neisseria meningitidis group B Neisseria meningitidis, Serogroup B Population Surveillance Product Surveillance, Postmarketing Public health Regulatory approval Response rates Student health services Students Surveys and Questionnaires Universities Vaccination - adverse effects Vaccines Young Adult |
| title | Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T02%3A07%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20surveillance%20for%20health%20events%20following%20a%20mass%20meningococcal%20B%20vaccine%20program%20in%20a%20university%20setting:%20A%20Canadian%20Immunization%20Research%20Network%20study&rft.jtitle=Vaccine&rft.au=Langley,%20J.M&rft.date=2016-07-25&rft.volume=34&rft.issue=34&rft.spage=4046&rft.epage=4049&rft.pages=4046-4049&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2016.06.025&rft_dat=%3Cproquest_cross%3E4120765081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1805461308&rft_id=info:pmid/27302338&rft_els_id=1_s2_0_S0264410X16304388&rfr_iscdi=true |